Analyzing Monash IVF Group Limited's (ASX:MVF) track record of past performance is a valuable exercise for investors. It enables us to reflect on whether or not the company has met expectations, which is a powerful signal for future performance. Today I will assess MVF's recent performance announced on 30 June 2019 and compare these figures to its long-term trend and industry movements.

See our latest analysis for Monash IVF Group

Was MVF's recent earnings decline worse than the long-term trend and the industry?

MVF's trailing twelve-month earnings (from 30 June 2019) of AU$20m has declined by -7.0% compared to the previous year.

Furthermore, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 11%, indicating the rate at which MVF is growing has slowed down. Why is this? Well, let’s take a look at what’s going on with margins and whether the rest of the industry is facing the same headwind.

In terms of returns from investment, Monash IVF Group has fallen short of achieving a 20% return on equity (ROE), recording 11% instead. However, its return on assets (ROA) of 8.1% exceeds the AU Healthcare industry of 5.0%, indicating Monash IVF Group has used its assets more efficiently. Though, its return on capital (ROC), which also accounts for Monash IVF Group’s debt level, has declined over the past 3 years from 18% to 12%.

What does this mean?

While past data is useful, it doesn’t tell the whole story. Companies that are profitable, but have unpredictable earnings, can have many factors influencing its business. I recommend you continue to research Monash IVF Group to get a better picture of the stock by looking at:

1. Future Outlook: What are well-informed industry analysts predicting for MVF’s future growth? Take a look at our free research report of analyst consensus for MVF’s outlook.

2. Financial Health: Are MVF’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.

3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

NB: Figures in this article are calculated using data from the trailing twelve months from 30 June 2019. This may not be consistent with full year annual report figures.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.